tiprankstipranks
Trending News
More News >
Immunicum AB (SE:IMMU)
:IMMU
Sweden Market

Immunicum AB (IMMU) Income Statement

Compare
0 Followers

Immunicum AB Income Statement

Last quarter (Q4 2024), Immunicum AB's total revenue was kr0.00, a decrease of -100.00% from the same quarter last year. In Q4, Immunicum AB's net income was kr-31.52M. See Immunicum AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
kr 28.49Mkr 3.00Mkr 6.00Kkr 0.00kr 16.67M
Gross Profit
kr 28.49Mkr -1.85Mkr -1.84Mkr -1.77Mkr 15.03M
Operating Expenses
kr 129.14Mkr 134.70Mkr 129.28Mkr 85.96Mkr 131.64M
Depreciation and Amortization
kr 3.37Mkr 4.85Mkr 1.85Mkr 1.77Mkr 1.64M
EBITDA
kr -97.85Mkr -128.67Mkr -128.28Mkr -84.25Mkr -43.22M
Operating Income
kr -100.65Mkr -133.68Mkr -130.10Mkr -86.03Mkr -132.32M
Other Income/Expenses
kr -969.00Kkr -5.10Mkr -3.31Mkr -3.22Mkr -2.92M
Pretax Income
kr -101.62Mkr -138.78Mkr -133.41Mkr -89.25Mkr -134.02M
Net Income
kr -101.62Mkr -136.99Mkr -136.69Mkr -92.47Mkr -135.71M
Per Share Metrics
Basic EPS
kr -4.40kr -0.63kr -0.68kr -1.12kr -1.69
Diluted EPS
kr -4.39kr -0.63kr -0.68kr -1.12kr -1.69
Weighted Average Shares Outstanding
23.10M 216.49M 199.75M 82.75M 80.24M
Weighted Average Shares Outstanding (Diluted)
23.13M 216.49M 199.75M 82.75M 80.24M
Currency in SEK

Immunicum AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis